As the first innovative Contract Research Organization (CRO) in China, we are focuses on innovative strategies and design of innovative drugs for serious diseases such as cancer. We are dedicated to providing services for new drug research and development and other supporting services to global and Chinese pharmaceutical and biotechnology companies. We have extensive experience in the design, data management, statistical analysis, medicine, clinical pharmacology and pharmacovigilance of clinical trials. Our business involves chemical drugs, biological products and cell therapy, with in-depth research in pediatrics, rare diseases and bridging trials.

In the past few years, the team has completed dozens of INDs filings, and completed dozens of clinical trials of new class 1 anti-tumor drugs, including biological drugs and chemical drugs. We are focus on the development of clinical trial plans, provide strategic design, and help customers achieve clinical trials with the lowest sample size and lowest time cost. We are focus on innovative drug design, especially anti-tumor clinical trials. By using Bayesian design methods to help drug development, we can achieve China and the United States applications.

We create the unique brand characteristics and core competitiveness in the industry, and create our greatest value for our partners. We strive to build a scientific, professional, standardized and efficient clinical trial team, and contribute to the development of new drugs to cure major diseases such as tumors.